Excedr clients get $5,000 off a proof-of-concept study for optimized assay development using AI and imaging tools.
ViQi partners with life sciences teams to modernize assay development using custom AI and imaging workflows. Their scientists work directly with your lab to design and deploy image-based assays that reduce variability, improve reproducibility, and accelerate turnaround times, without changing your core biology.
ViQi offers a low-lift, $5K-off proof-of-concept study designed to demonstrate value in just 4 to 6 weeks. Whether you're optimizing viral titration, inactivation, neutralization, or clearance workflows, or seeking better insight into off-target effects, our software platform integrates seamlessly with your existing assays and infrastructure. No new hardware required. Just smarter, faster assays that are ready for scale.
Excedr clients can take advantage of this proof-of-concept study—built to help teams accelerate assay development using AI and imaging, without disrupting existing workflows.
Custom Assays, Guided by Scientists – Powered by AI.
ViQi partners with biotech and pharma teams to deliver AI-driven imaging solutions that go beyond today's challenges.
Their cross-disciplinary scientists design custom assays that seamlessly integrate into existing workflows, accelerate data insights, and support critical regulatory compliance across development pipelines.
To sign up and qualify, you must have done one of the following within the past year:
Driven by robust workflows, Danaher experts will help you personalize your lab by providing solution offerings to meet your needs.
Discounts are available with further savings possible depending on your new launch requirements.